Skip to main content
Clinical Trials/CTRI/2023/12/060743
CTRI/2023/12/060743
Not yet recruiting
未知

Phenotype, clinical profile and treatment eligibility of Hepatitis-B infected patients lying in gray zone in a tertiary care center of Eastern India - an observational study. - NI

I.P.G.M.R, Kolkata0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B181- Chronic viral hepatitis B withoutdelta-agent
Sponsor
I.P.G.M.R, Kolkata
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
I.P.G.M.R, Kolkata

Eligibility Criteria

Inclusion Criteria

  • Hepatitis B patients
  • 1\. Age \> 18 years
  • 2\. Fulfilling Gray zone criteria
  • a) Grey zone A (GZ\- A): HBeAg positive, normal ALT levels and serum HBV DNA \<106 IU/ml;
  • b) Grey zone B (GZ\- B): HBeAg positive, elevated ALT levels and serum HBV DNA \<2 × 104 IU/ml;
  • c) Grey zone C (GZ\- C): HBeAg negative, normal ALT levels and serum HBV DNA \<2 × 10 3 IU/ml;
  • d) Grey zone D (GZ\- D): HBeAg negative, elevated ALT levels and serum HBV DNA \>2 × 10 3 IU/ml.

Exclusion Criteria

  • 1\. subjects unwilling to give consent
  • 2\. subjects on treatment or features of Cirrhosis

Outcomes

Primary Outcomes

Not specified

Similar Trials